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Tumor necrosis factor-α (TNF-α) triggers activation of cytosolic phospholipase A2
(cPLA2) and then enhancing the synthesis of prostaglandin (PG) in inflammatory
diseases. However, the detailed mechanisms of TNF-α induced cPLA2 expression
were not fully defined in human pulmonary alveolar epithelial cells (HPAEpiCs). We
found that TNF-α-stimulated increases in cPLA2 mRNA (5.2 folds) and protein (3.9
folds) expression, promoter activity (4.3 folds), and PGE2 secretion (4.7 folds) in
HPAEpiCs, determined by Western blot, real-time PCR, promoter activity assay and
PGE2 ELISA kit. These TNF-α-mediated responses were abrogated by the inhibitors of
NADPH oxidase [apocynin (APO) and diphenyleneiodonium chloride (DPI)], ROS [N-
acetyl cysteine, (NAC)], NF-κB (Bay11-7082) and transfection with siRNA of ASK1,
p47phox, TRAF2, NIK, IKKα, IKKβ, or p65. TNF-α markedly stimulated NADPH oxidase
activation and ROS including superoxide and hydrogen peroxide production which
were inhibited by pretreatment with a TNFR1 neutralizing antibody, APO, DPI or
transfection with siRNA of TRAF2, ASK1, or p47phox. In addition, TNF-α also stimulated
p47phox phosphorylation and translocation in a time-dependent manner. On the other
hand, TNF-α induced TNFR1, TRAF2, ASK1, and p47phox complex formation in
HPAEpiCs, which were attenuated by a TNF-α neutralizing antibody. We found that
pretreatment with NAC, DPI, or APO also attenuated the TNF-α-stimulated IKKα/β and
NF-κB p65 phosphorylation, NF-κB (p65) translocation, and NF-κB promoter activity in
HPAEpiCs. Finally, we observed that TNF-α-stimulated NADPH oxidase activation and
ROS generation activates NF-κB through the NIK/IKKα/β pathway. Taken together, our
results demonstrated that in HPAEpiCs, up-regulation of cPLA2 by TNF-α is, at least in
part, mediated through the cooperation of TNFR1, TRAF2, ASK1, and NADPH oxidase
leading to ROS generation and ultimately activates NF-κB pathway.
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INTRODUCTION
The occurrence and exacerbation of lung diseases, including
chronic obstructive pulmonary disease (COPD) and asthma,
is dependent on the severity of lung inflammation (Lee and
Yang, 2012). Eicosanoids, one of lipid mediators generating
from conversion of arachidonic acid (AA), have been found in
situ in airway secretion of asthmatics (Barnes, 1989; Henderson
et al., 2002). Phospholipase A2 (PLA2) enzymes catalyze the
hydrolysis of membrane phospholipids resulting in the release
of AA (Borsch-Haubold et al., 1998). The constitutive enzyme
cyclooxygenase (COX)-1 or the inducible COX-2 then converts
AA to prostaglandins (PGs), such as PGE2 (Yang et al.,
2002; Hsieh et al., 2006). Three PLA2 have been identified
including secretory PLA2, the 85 kDa cytosolic group IV
PLA2 (cPLA2), and a calcium-independent group VI PLA2
in mammalian cells (Six and Dennis, 2000). cPLA2 plays
a major role in agonist-induced AA release and eicosanoid
production (Leslie, 1997). Involvement of cPLA2 in sepsis-
related acute lung injury (Nagase et al., 2000) and anaphylaxis-
associated bronchial reactivity has been proved (Uozumi et al.,
1997). Furthermore, PGE2 synthesis increases are dependent on
upregulation of cPLA2 activity in various cell types (Dieter et al.,
2002; Gilroy et al., 2004). Elevated levels of TNF-α have been
detected in the bronchoalveolar lavage fluid of asthmatic patients.
TNF-α could exaggerate inflammatory responses through up-
regulation of inflammatory genes, such as cPLA2 (Hulkower
et al., 1994; Van Putten et al., 2001). Up-regulation of cPLA2
further catalyzes the hydrolysis of membrane phospholipids
and releases AA served as a substrate for PGs synthesis
(i.e., PGE2) that augments lung inflammation. Moreover, our
previous findings also provided insights into the correlation
between COX-2 and cPLA2 expression in ATPγS-stimulated
vascular smooth muscle cells (VSMCs) with similar molecular
mechanisms and functional coupling to amplify the occurrence
of vascular inflammation (Lin et al., 2009). Therefore, the
synthesis of PGE2 could be a good index of AA release that
is more sensitive than [3H]AA mobilization (Berenbaum et al.,
2003). In this study, although the effect of TNF-α on COX-
2 expression was not investigated, we tested the effect of
TNF-α on PGE2 synthesis as a parameter of cPLA2 activity
in human pulmonary alveolar epithelial cells (HPAEpiCs).
Therefore, up-regulation of cPLA2 may play a key role in
local and systemic inflammation in airway diseases. However,
the molecular mechanisms by which TNF-α induces cPLA2
expression and PGE2 synthesis in HPAEpiCs are not completely
understood.
Previous report indicates that TNF-α binds to distinct
receptors, TNFR1 and TNFR2, and triggers various inflammatory
responses (Lee et al., 2009). The association of TNF-α and
TNFR1 modulates the severity of tissue injury via activation
of proinflammatory or programmed cell death pathway (van
Vliet et al., 2005; Lee et al., 2009). TNF receptor associated
factor 2 (TRAF2) plays an important role in innate immune and
inflammatory responses. However, the interaction among TNF-α,
TNFR1, TRAF2 and downstream components leading to cPLA2
expression is still unknown in HPAEpiCs.
Reactive oxygen species (ROS) are products of normal
cellular metabolism acting as second messengers (Lee and
Yang, 2012). However, either reduced nicotinamide adenine
dinucleotide phosphate (NADPH) by pro-inflammatory
cytokines such as TNF-α or the mitochondrial electron transport
chain and xanthine oxidase leads to increased production
of ROS and unbalance of cellular oxidative stress, which are
causes of airway/lung damages and subsequently respiratory
inflammatory diseases/injuries (Lee and Yang, 2012). Apoptosis
signal-regulating kinase 1 (ASK1), a mitogen-activated protein
kinase kinase kinase, participates in regulating stress and
immune responses. ASK1 is activated by cytokines and various
environmental and cellular stresses. Hsu et al. indicated that
peptidoglycan (PGN) induced COX-2 expression via an ASK1
signaling in A549 cells (Hsu et al., 2010). Therefore, we explored
whether TNFR1, TRAF2, ASK1, and NADPH oxidase/ROS are
involved in TNF-α-induced cPLA2 expression and PGE2 release.
NF-κB plays major roles not only in the evolution but
also in the resolution of inflammatory responses. A wide
spectrum of biological effects including immune and stress-
induced responses, proliferation, differentiation, tumorigenesis,
apoptosis, and tissue remodeling are all controlled by activated
NF-κB (Lee and Yang, 2012). The activation of NF-κB can be
regulated by various extracellular stimuli, including cytokines
and oxidative stress (Lee and Yang, 2012). We noticed that ROS
generation can impact NF-κB signaling pathways (Morgan and
Liu, 2011). In addition, NF-κB modulates cPLA2 gene activity in
various cell types (Luo et al., 2006; Huwiler et al., 2012; Chi et al.,
2014). Therefore, we examined whether TNF-α regulates cPLA2
expression via ROS-dependent NF-κB activation in HPAEpiCs.
In addressing these questions, the experiments were
performed to investigate the mechanisms underlying
TNF-α-induced cPLA2 expression and PGE2 synthesis in
HPAEpiCs. These findings suggested that TNF-α-induced
cPLA2-expression associated PGE2 release is, at least in part,
mediated through a TNFR1/TRAF2/ASK1/p47phox/NADPH
oxidase/ROS/NIK/IKKα/β/NF-κB pathway in these cells.
MATERIALS AND METHODS
Materials
Recombinant human TNF-α was from R&D System
(Minneapolis, MN, USA). Anti-cPLA2 (sc-454), anti-p47phox
(sc-14015), anti-Gαs (sc-823), anti-TRAF2 (sc-7346), anti-
ASK1 (sc-5294), anti-TNFR1 (sc-52739), anti-NIK (sc7211),
anti-IKKα (sc7218), anti-IKKβ (sc8014), anti-p65 (sc-7151)
and anti-phospho-serine (sc-81515) antibodies were from
Santa Cruz (Santa Cruz, CA). An anti-GAPDH antibody
(#MCA-1D4) was from Encor (Gainesville, FL, USA). Human
TNF-α neutralizing antibody (#7321), anti-phospho-tyrosine
(#9411), anti-phospho-ASK1 (#3765), anti-phospho-p65
(#3031), and anti-phospho-IKKα/β (#2697) antibodies were
from Cell Signaling (Danvers, MA, USA). N-Acetyl cysteine
(NAC), diphenyleneiodonium chloride (DPI), apocynin
(APO), and Bay11-7082 were from Biomol (Plymouth
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Meeting, PA, USA). Dihydroethidium (DHE) and 5-(and-6)-
chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate, acetyl
ester (CM-H2DCFDA) were from Molecular Probes (Eugene,
OR, USA). SDS-PAGE supplies were from MDBio Inc (Taipei,
Taiwan). All other reagents were from Sigma (St. Louis, MO,
USA).
Cell Culture and Treatment
Human pulmonary alveolar epithelial cells (HPAEpiCs) were
ordered from ScienCell Research Lab (San Diego, CA, USA).
The passages 4–7 were used throughout this study. HPAEpiCs
were cultured in DMEM/F12 medium containing 10% FBS,
as previously described Lee et al. (2008). The growth medium
was changed after 48 h and then every 3 days. The viability of
HPAEpiCs after treatment with DMSO or the pharmacological
inhibitors alone was determined by an XTT [2,3-bis-(2-methoxy-
4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide] assay,
which showed no significant differences (data not shown).
Western Blot Analysis
Serum-starved HPAEpiCs were incubated with TNF-α at 37◦C
for the various time points. At the end of treatment, the cells
were harvested and centrifuged at 45000 × g at 4◦C for 1 h
to prepare the whole cell lysate, as previously described (Chi
et al., 2012). The denatured samples were analyzed by 10%
SDS-PAGE gels and transferred to nitrocellulose membrane.
The Western blot was performed by incubation membrane with
an anti-cPLA2, anti-p47phox, anti-Gαs, anti-TRAF2, anti-ASK1,
anti-TNFR1, anti-NIK, anti-IKKα, anti-IKKβ, anti-p65, anti-
phospho-serine or anti-GAPDH (1:1000) antibody for 24 h,
and then incubated with an anti-mouse horseradish peroxidase
antibody (1:2000) for 1 h. ECL reagents and UVP BioSpectrum
500 Imaging System (Upland, CA, USA) were used to detect and
capture the immunoreactive bands. The image densitometry of
each immunoreactive band was analyzed and quantified by the
UN-SCAN-IT gel software (Orem, UT, USA).
Real-Time PCR Analysis
Total RNA of HPAEpiCs was extracted using TRIzol reagent
and reverse-transcribed into cDNA. Real-time PCR using
SYBR Green PCR reagents (Applied Biosystems, Branchburg,
NJ, USA) and primers specific for cPLA2 and GAPDH genes
were used, as previously described (Chi et al., 2012). The
real-time primers were as follows: cPLA2α, forward primer:
5′-ATGATAGCTCGGACAGTGATGATGA-3′; reverse primer:
5′-CATACGATGAATCCAACTTGCTTGA-3′ and GAPDH,
forward primer: 5′-CTCTGCTCCTCCTGTTCGAC-3′; reverse
primer: 5′-TTAAAAGCAGCCCTGGTGAC-3′. The expression
of cPLA2 was quantified by normalization to the GAPDH
expression.
Measurement of Intracellular ROS
Accumulation
The intracellular H2O2 levels were determined by measuring
fluorescence of 2′,7′-dichloro fluorescein diacetate (DCF-DA)
and the O•−2 levels were determined by measuring the level
of dihydroethidium (DHE), as previously described Hsu et al.
(2014). The fluorescence for DCF and DHE staining was detected
at 495/529 and 518/605 nm, respectively, using a fluorescence
microscope (Zeiss, Axiovert 200M). For the purpose of these
experiments, HPAEpiCs were washed with warm HBSS and
incubated in HBSS or cell medium containing 10 µM DCFH-
DA or DHE at 37◦C for 45 min. Subsequently, HBSS or
medium containing DCFH-DA or DHE was removed and
replaced with fresh medium. HPAEpiCs were then incubated
with TNF-α. Cells were washed twice with PBS and detached
with trypsin/EDTA, and the fluorescence intensity of the cells was
analyzed using a multi-technology reader (Thermo, Appliskan) at
Ex/Em: 485/530 nm.
Determination of NADPH Oxidase
Activity by Chemiluminescence Assay
HPAEpiCs (2 × 106 cells/ml) were cultured in 6-well plates
and then incubated with TNF-α after growth to confluence and
serum-starved. At the end of incubation, cells were harvested
and centrifuged at 400 × g for 10 min at 4◦C. The cell pellet
was kept on ice after re-suspended by 35 µl/per well of ice-cold
RPMI-1640 medium. The complex including NADPH (1 µM)
or lucigenin (20 µM), 5 µl of cell suspension (0.2 × 105
cells) and a final 200 µl volume of pre-warmed (37◦C) RPMI-
1640 medium were prepared and the chemiluminescence was
immediate recorded with an Appliskan luminometer (Thermo R©)
in out-of-coincidence mode. Appropriate blanks and controls
were used. There was no background chemiluminescence of
lucigenin in NADPH or NADH alone group (30–40 counts per
min), as previously described Hsu et al. (2014). The signals of
chemiluminescence were continuously measured for 12 min, and
the activity of NADPH oxidase was expressed as counts per
million cells.
Measurement of cPLA2 Luciferase
Activity
Human cPLA2 promoter spanning − 2375 to +75 bp as cloned
into pGL3-basic vector (Promega, Madison, WI, USA) as cPLA2-
luc plasmid. The activity of cPLA2-luc was detected using
a luciferase assay system (Promega, Madison, WI, USA), as
previously described Chi et al. (2012). The detected luciferase
activities were standardized with the activity of β-gal.
Measurement of PGE2 Generation
The serum-starved cells were treated with TNF-α for the different
time points. At the end of treatment, culture media were collected
and stored at −80◦C. The concentrations of PGE2 were detected
by a PGE2 enzyme immunoassay kit (Cayman) according to the
manufacturer’s instructions, as previously described Lee et al.
(2008).
Transient Transfection with siRNAs
All human ASK1, p47phox, TRAF2, NIK, IKKα, IKKβ, and p65
siRNA together with scramble siRNA were purchased from Sigma
(St. Louis, MO, USA). LipofectamineTM RNAiMAX reagents
were used to prepare siRNA liposome complexes (100 nM
Frontiers in Pharmacology | www.frontiersin.org 3 November 2016 | Volume 7 | Article 447
fphar-07-00447 November 23, 2016 Time: 17:3 # 4
Lin et al. TNF-α-Induced cPLA2 Expression
of siRNAs) according to the manufacturer’s instructions, as
previously described Lee et al. (2008).
Co-immunoprecipitation Assay
Cell lysates containing 1 mg of protein were incubated with
2 µg of an anti-p47phox, anti-TNFR1, anti-TRAF2, or anti-
ASK1 antibody at 4◦C for 24 h, and then 10 µl of 50%
protein A-agarose beads was added and mixed at 4◦C for 24 h.
The immunoprecipitates were collected and washed thrice with
a lysis buffer without Triton X-100. 5x Laemmli buffer was
added and subjected to electrophoresis on SDS-PAGE, and then
blotted using an anti-phospho-tyrosine, anti-phospho-serine,
anti-p47phox, anti-TRAF2, anti-TNFR1, or anti-ASK1 antibody,
as previously described (Yang et al., 2014).
Immunofluorescence Staining
Growth-arrested HPAEpiCs were incubated with TNF-α for
the indicated time intervals. After washing twice with ice-
cold PBS, cells were fixed, permeabilized and stained using an
anti-p65 antibody, as previously described (Chi et al., 2011).
A fluorescence microscope (Zeiss, Axiovert 200M) were used to
observe images.
Cell Fractions Isolation
The cell lysates were sonicated for 5 s at output 1.5 using a
sonicator (Misonix, Farmingdale, NY, USA) and then centrifuged
at 6800 × g for 15 min at 4◦C, as previously described Lee
et al. (2008). The pellet was collected as the nuclear fraction.
The supernatant was further centrifuged at 20,000 × g at 4◦C
for 60 min to yield the pellet (membrane fraction) and the
supernatant (cytosolic fraction).
Statistical Analysis of Data
Data were showed as the mean or mean± SEM of five individual
experiments and estimated using GraphPad Prism Program
(GraphPad, San Diego, CA, USA). All the data were analyzed
by paired two-tailed Student’s t-test or by one-way analysis of
variance (ANOVA) followed with Tukey’s post hoc test at p< 0.05
level of significance.
RESULTS
TNF-α Induces cPLA2 Expression via
NADPH Oxidase and ROS
Reactive oxygen species play both deleterious and beneficial
roles. Accumulation of ROS and cellular oxidative stress
trigger expression of inflammatory genes and result in tissue
damages and various diseases (Lee and Yang, 2012). Thus,
we attempted to investigate the roles of NADPH Oxidase
and ROS in cPLA2 expression. Here we reported that TNF-
α-induced cPLA2 protein levels were significantly reduced by
pretreatment with a ROS scavenger (NAC) or the inhibitors
of NADPH oxidase (APO and DPI) (Figure 1A). In addition,
pretreatment with NAC, DPI, or APO also attenuated the
TNF-α-stimulated cPLA2 mRNA expression and promoter
activity (Figure 1B). The p47phox protein, one of cytosolic
subunits of NADPH oxidase, contributed to acute NADPH
oxidase activation via being phosphorylated and binding to
p22phox (Lee et al., 2009). Thus, we confirmed the role of
p47phox in cPLA2 expression by transfection with p47phox siRNA
which knocked down protein expression of p47phox and then
markedly inhibited TNF-α-induced cPLA2 protein expression
in these cells (Figure 1C). To confirm this cPLA2 expression
is mediated through TNF-α-dependent induction, HPAEpiCs
were pretreated with a human TNF-α neutralizing antibody
followed by TNF-α treatment. We found that TNF-α neutralizing
antibody significantly blocked the cPLA2 induction in a dose-
dependent manner (Figure 1D). These results indicated that
TNF-α induces cPLA2 expression via NADPH oxidase and ROS
in HPAEpiCs.
TNF-α Induces NADPH
Oxidase-Dependent Superoxide and
Hydrogen Peroxide Production
TNF-α may stimulate ROS production by several sources, such
as mitochondria, but recent studies have strongly suggested that
a major source of ROS is a phagocyte-type NADPH oxidase.
Several reports also demonstrate that TNF-α triggers several
signal transduction pathways to activate the NOX activity and
enhances intracellular ROS generation leading to expression of
inflammatory genes (Rahman et al., 1998; Hashimoto et al., 2001;
Li et al., 2005; Lee et al., 2013; Yang et al., 2014). Therefore, we
investigated whether TNF-α-induced cPLA2 expression is due
to activation of NADPH oxidase and ROS generation. Here, we
found that TNF-α markedly induced superoxide and hydrogen
peroxide production, determined by using DHE or DCF under
a fluorescence microscope (Figure 2A). On the other hand, we
also observed that TNF-α time-dependently induces NADPH
oxidase activation (Figure 2B), which was reduced by TNFR1
neutralizing antibody, APO, or DPI (Figure 2C). These results
suggested that TNF-α induced ROS generation via NADPH
oxidase activation. The p47phox is phosphorylated on several
serine residues within the polybasic region of the protein, and
these multiple phosphorylation events induce conformational
changes that permit p47phox to interact with the cytoplasmic
tail of p22phox and to initiate the formation of the active
NADPH oxidase complex (Dang et al., 2006). Previous report
also indicates that Src modulates tyrosine phosphorylation of
p47phox in hyperoxia-induced activation of NADPH oxidase
and generation of ROS in lung endothelial cells (Chowdhury
et al., 2005). Thus, we investigated whether TNF-α stimulates the
phosphorylation of tyrosine or serine on p47phox. As shown in
Figure 2D, TNF-α increased tyrosine and serine phosphorylation
of p47phox in a time-dependent manner. Moreover, p47phox was
translocated from the cytosol to the membrane fractions in TNF-
α-stimulated cells (Figure 2E). Finally, we investigated whether
TNF-α-induced superoxide and hydrogen peroxide production
are mediated through NADPH oxidase activation. Here, we
observed that TNF-α-induced superoxide and hydrogen peroxide
production were inhibited by TNFR1 neutralizing antibody,
APO, DPI and NAC (Figure 2F). These results suggested that
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FIGURE 1 | TNF-α induces NADPH oxidase- and ROS-dependent cPLA2 expression. (A) HPAEpiCs were pretreated with NAC, DPI, or APO for 1 h, and
then incubated with TNF-α for 24 h. (B) Cells were pretreated with NAC (10 mM), DPI (1 µM), or APO (100 µM) for 1 h, and then incubated with TNF-α for 6 h.
cPLA2 mRNA levels and promoter activity were determined. (C) Cells were transfected with scrambled or p47phox siRNA, and then incubated with TNF-α for 24 h.
(D) HPAEpiCs were pretreated with human TNF-α neutralizing antibody (TNF-α nAb: 0.01, 0.1 and 1 µg/ml) for 1 h, and then incubated with TNF-α for 24 h. (A,C,D)
The protein levels of cPLA2 and p47phox were determined by Western blot. Data are expressed as mean ± SEM of three independent experiments. ∗P < 0.05,
#P < 0.01 as compared with the cells exposed to TNF-α alone.
TNF-α induces ROS generation via p47phox translocation and
NADPH oxidase activation in HPAEpiCs.
TNF-α Induces TNFR1, TRAF2, ASK1,
and p47phox Complex Formation
Both tissue injury-related proinflammatory and programmed
cell death pathways are activated by TNF-α via binding to
TNFR1 (van Vliet et al., 2005; Lee et al., 2009). TRAF2
plays an important role in innate immune and inflammatory
responses. Thus, we determine whether TRAF2 is a downstream
component of TNF-α/TNFR1 complex in cPLA2 expression.
Here, we demonstrated that TNF-α induced cPLA2 expression
via TRAF2 by transfection with TRAF2 siRNA (Figure 3A).
We found that transfection with TRAF2 siRNA reduced
TRAF2 protein expression by about 50% and significantly
attenuated the TNF-α-induced cPLA2 expression from 5.4-
fold to 2.2-fold. In addition, we also showed that TNF-α
stimulated TRAF2 and TNFR1 complex formation and its
downstream components (Figure 3B). Therefore, we further
studied whether TNF-α promoted the association of TNFR1,
TRAF2, ASK1, and p47phox in HPAEpiCs. Data in Figure 3B
showed that TNF-α time-dependently induced TNFR1, TRAF2,
ASK1, and p47phox complex formation. Importantly, this
interaction was blocked by pretreatment with TNF-α neutralizing
antibody.
Various cell stresses, including ROS, TNF-α,
lipopolysaccharide (LPS), and ER stress, activate ASK1 and
resulting in apoptosis, differentiation and inflammation (Soga
et al., 2012). However, whether ASK1 involved in TNF-
α-mediated responses was still unknown in HPAEpiCs. Here, we
found that transfection with ASK1 siRNA knocked down ASK1
protein level by about 50% and then significantly attenuated
the TNF-α-induced cPLA2 expression from 4.9-fold to 1.9-fold
(Figure 3C). ASK1 plays a pivotal role in ROS generation. In
resting cells, endogenous ASK1 constitutively associated with
thioredoxin (Trx) forming an inactive high-molecular-mass
complex, known as ASK1 signalosome. Once cellular ROS
increased, Trx dissociated from ASK1 signalosome and resulted
in full activation of higher-molecular-mass complex by the
recruitment of TRAF2 and TRAF6 (Fujino et al., 2007). Thus,
we further investigated whether p47phox was recruited to the
complex of TNF-α/TNFR1/TRAF2/ASK1. We observed that
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FIGURE 2 | TNF-α induces NADPH oxidase-dependent ROS generation. (A) HPAEpiCs were treated with TNF-α for the indicated time intervals. DHE (red) or
DCF (green) fluorescence image was observed. Images shown are representative of five independent experiments with similar results. Cells were (B) treated with
TNF-α for the indicated time intervals or (C) pretreated with TNFR1 neutralizing antibody (10 µg/ml), APO (100 µM), or DPI (1 µM) for 1 h, and then treated with
TNF-α for 10 min. NADPH oxidase activity was measured. (D) Cells were treated with TNF-α for the indicated time intervals. The cell lysates were subjected to
immunoprecipitation using an anti-p47phox antibody, and then the immunoprecipitates were analyzed by Western blot using an anti-phospho-tyrosine,
anti-phospho-serine, or anti-p47phox antibody. (E) Cells were treated with TNF-α for the indicated time intervals. The cytosolic and membrane fractions were
prepared and analyzed by Western blot using an anti-p47phox , anti-Gαs, or anti-GAPDH antibody. GAPDH and Gαs were used as a marker protein for cytosolic and
membrane fractions, respectively. (F) Cells were pretreated with TNFR1 neutralizing antibody, NAC, APO, or DPI for 1 h, and then incubated with TNF-α for 10 min.
H2O2 and superoxide generation were measured. Data are expressed as mean ± SEM of three independent experiments. ∗P < 0.05, #P < 0.01 as compared with
the cells exposed to vesicle alone (B) or TNF-α alone (C,F).
TNF-α time-dependently induced TNFR1, TRAF2, ASK1, and
p47phox complex formation determined by immunoprecipitation
(Figure 3B). Consistently, this interaction was also blocked by
pretreatment with a TNF-α neutralizing antibody. To confirm
whether ASK1 phosphorylation is necessary for TNF-α-induced
cPLA2 expression, activation of the ASK1 was assayed by
Western blot using an antibody specific for the phosphorylated
form of ASK1. We found that TNF-α significantly stimulated
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FIGURE 3 | TNF-α induces TNFR1/TRAF2/ASK1/p47phox complex formation. (A) HPAEpiCs were transfected with scrambled or TRAF2 siRNA, and then
incubated with TNF-α for 24 h. The protein levels of TRAF2 and cPLA2 were determined. (B) Cells were pretreated without or with human TNF-α neutralizing
antibody (TNF-α nAb:1 µg/ml) for 1 h and then incubated with TNF-α for the indicated time intervals. The cell lysates were subjected to immunoprecipitation using an
anti-TNFR1, anti-TRAF2, anti-ASK1, or anti-p47phox antibody, and then the immunoprecipitates were analyzed by Western blot by using an anti-TNFR1, anti-TRAF2,
anti-ASK1, anti-p47phox or anti-IgG antibody. The results of IgG were used to be the loading control. (C) Cells were transfected with scrambled or ASK1 siRNA, and
then incubated with TNF-α for 24 h. The protein levels of ASK1 and cPLA2 were determined. (D) Cells were treated with TNF-α for the indicated time intervals. The
levels of phospho-ASK1 were determined by Western blot. Data are representative of three independent experiments with similar results. ∗P < 0.05, #P < 0.01 as
compared with the basal group.
ASK1 phosphorylation in a time-dependent manner (Figure 3D).
These results suggested that TNF-α stimulates TNFR1, TRAF2,
ASK1, and p47phox complex formation leading to NADPH
oxidase activation and ROS generation in HPAEpiCs.
TNF-α Induces NADPH Oxidase/ROS
Generation and PGE2 Release via TRAF2,
ASK1, and p47phox
Next, we investigated whether TRAF2, ASK1 and p47phox are
involved in TNF-α-induced ROS generation. As shown in
Figure 4A, transfection with TRAF2, ASK1, or p47phox siRNA
markedly inhibited TNF-α-induced superoxide and hydrogen
peroxide production. In addition, these siRNAs also inhibited
the TNF-α-induced NADPH oxidase activation (Figure 4B).
Moreover, our previous findings also provided the correlation
between COX-2 and cPLA2 expression in ATPγS-stimulated
VSMCs with similar molecular mechanisms and functional
coupling to amplify the occurrence of vascular inflammation
(Lin et al., 2009). Therefore, the synthesis of PGE2 could be a
good index of AA release that is more sensitive than [3H]AA
mobilization (Berenbaum et al., 2003). In this study, we tested
the effect of TNF-α on PGE2 synthesis as a parameter of cPLA2
activity in HPAEpiCs. Here, we observed that TNF-α-induced
PGE2 release was reduced by transfection with TRAF2, ASK1, or
p47phox siRNA (Figure 4C). These results suggested that TNF-α
induces ROS generation and PGE2 release via TRAF2, ASK1, and
p47phox in HPAEpiCs.
TNF-α Induces cPLA2 Expression via
NIK, IKKα/β, and NF-κB
NF-κB is mainly involved in stress-induced immune and
inflammatory responses. Activities of NF-κB are regulated by
various inflammatory cytokines such as TNF-α (Lee et al., 2007).
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FIGURE 4 | TNF-α induces NADPH oxidase/ROS generation and PGE2 release via TRAF2, ASK1, and p47phox. HPAEpiCs were transfected with
scrambled, ASK1, p47phox , or TRAF2 siRNA, and then incubated with TNF-α for (A,B) 10 min or (C) 24 h. (A) H2O2 and superoxide generation were measured.
(B) NADPH oxidase activity was measured. (C) PGE2 generation was measured. Data are expressed as mean ± SEM of three independent experiments. ∗P < 0.05,
#P < 0.01 as compared with the cells exposed to TNF-α + scrambled siRNA.
The signaling mechanisms mediated activation of NF-κB includes
canonical and non-canonical pathways (Tak and Firestein,
2001). The canonical pathway has been well documented
to regulate the pathophysiological functions; however, the
non-canonical NF-κB-inducing kinase (NIK) pathway is not
well understood in the expression of inflammatory genes
(Uno et al., 2014). NIK plays central roles in the activation
of non-canonical NF-κB pathway (Tak and Firestein, 2001;
Uno et al., 2014). NIK was first identified as a TRAF2
interacting protein. In addition, IκBs associate with NF-κB
being inactive forms. IκBs are phosphorylated by IKKα and
IKKβ then degradation via ubiquitination to release NF-κB and
nuclear translocation (Sun, 2011). Therefore, we investigated
whether TNF-α induced cPLA2 expression via NIK, IKKα,
and IKKβ by transfection with respective siRNAs. Transfection
with NIK, IKKα, or IKKβ siRNAs knocked down their own
protein levels and subsequently attenuated the TNF-α-induced
cPLA2 expression (Figure 5A). To ascertain whether NF-κB
participated in TNF-α-induced cPLA2 expression, a selective
pharmacological inhibitor of NF-κB, Bay11-7082, was used for
this purpose. Pretreatment with Bay11-7082 significantly reduced
the TNF-α-induced cPLA2 protein, mRNA, and promoter
activity (Figures 5B,C). Moreover, p65 siRNA was used to
confirm the role of NF-κB in TNF-α-mediated effects. In
addition, transfection with p65 siRNA also reduced TNF-
α-induced cPLA2 expression (Figure 5D) and PGE2 secretion
(Figure 5E) in these cells. The non-canonical NF-κB pathway
is activated through particular TNF-α receptors that bind
to the TRAF2 which leads to translocation of NF-κB into
nucleus and induction of target gene expression (Tak and
Firestein, 2001). Therefore, the translocation of NF-κB p65
was observed by an immunofluorescence microscope. Our
findings showed that TNF-α time-dependently stimulated NF-
κB p65 translocation from the cytosol into the nucleus fractions
(Figure 5F) together with enhancing NF-κB promoter activity
(Figure 5G). These results suggested that TNF-α-induced cPLA2
expression is mediated through NIK, IKKα/β, and NF-κB in these
cells.
TNF-α Induces NIK/IKKα/β-Dependent
NF-κB Activation
In this study, we investigated whether TNF-α stimulates
NF-κB p65 activation via an NADPH oxidase/ROS-dependent
pathway. As shown in Figure 6A, TNF-α markedly stimulated
NF-κB p65 phosphorylation which was inhibited by NAC,
DPI, APO or Bay11-7082. In addition, pretreatment with
NAC, DPI, or APO also inhibited TNF-α-induced NF-
κB promoter activity and NF-κB p65 translocation in
HPAEpiCs (Figures 6B,C). On the other hand, we also
observed that TNF-α significantly stimulated IKKα/β
phosphorylation in a time-dependent manner, which
was reduced by NAC, DPI or APO (Figure 6D). Finally,
we investigated whether TNF-α stimulates NF-κB p65
phosphorylation via an NIK/IKKα/β pathway. As shown
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FIGURE 5 | TNF-α induces cPLA2 expression via NIK, IKKα/β, and NF-κB. (A) HPAEpiCs were transfected with scrambled, NIK, IKKα, or IKKβ siRNA, and
then incubated with TNF-α for 24 h. The protein levels of NIK, IKKα, IKKβ, and cPLA2 were determined by Western blot. (B) Cells were pretreated with Bay11-7082
for 1 h, and then incubated with TNF-α for 24 h. The protein levels of cPLA2 were determined by Western blot. (C) Cells were pretreated with Bay11-7082 for 1 h,
and then incubated with TNF-α for 6 h. cPLA2 mRNA levels and promoter activity were determined. (D) Cells were transfected with scrambled or p65 siRNA, and
then incubated with TNF-α for 24 h. The protein levels of p65 and cPLA2 were determined. (E) Cells were pretreated with Bay11-7082 for 1 h, and then incubated
with TNF-α for 24 h. PGE2 generation was measured. (F) Cells were incubated with TNF-α for the indicated time intervals. Cells were fixed, labeled with an anti-p65
antibody, and then FITC-conjugated secondary antibody. Individual cells were imaged. (G) Cells were incubated with TNF-α for the indicated time intervals. NF-κB
promoter activity was determined. Data are expressed as mean ± SEM of three independent experiments. ∗P < 0.05, #P < 0.01 as compared with the cells
exposed to TNF-α alone (C,E) or vesicle alone (G).
in Figure 6E, transfection with NIK siRNA attenuated the
TNF-α-induced IKKα/β and NF-κB p65 activation. In addition,
transfection with siRNA of IKKα or IKKβ markedly inhibited
TNF-α-induced NF-κB p65 phosphorylation (Figure 6E).
These results suggested that TNF-α stimulates NF-κB p65
activation through an NIK/IKKα/β-dependent cascade in
HPAEpiCs.
DISCUSSION
Various degrees of inflammation and tissue remodeling are
characteristics of different pulmonary disorders including asthma
and COPD. Expression of cPLA2 by mesenchymal cells in
several extra-pulmonary sites contributes to the production of
PGE2 which functions as biologically active lipid mediators in
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FIGURE 6 | TNF-α induces NIK/IKKα/β-dependent NF-κB activation. (A) HPAEpiCs were pretreated with NAC (10 mM), DPI (1 µM), APO (100 µM) or
Bay11-7082 (10 µM) for 1 h, and then treated with TNF-α for the indicated time intervals. The levels of p65 phosphorylation were determined by Western blot. The
raw data of the GAPDH of (A) were provided with a supplementary data (Supplementary Figure S2). (B) Cells were pretreated with NAC, DPI, or APO for 1 h, and
then treated with TNF-α for 2 h. NF-κB promoter activity was determined. (C) Cells were pretreated with NAC, DPI, or APO for 1 h, and then treated with TNF-α for
the indicated time intervals. The nuclear fractions were prepared and analyzed by Western blot using an anti-p65 antibody. Lamin A was used as a marker protein for
nuclear fractions. (D) Cells were pretreated with NAC, APO, or DPI for 1 h, and then treated with TNF-α for the indicated time intervals. The levels of IKKα/β
phosphorylation were determined by Western blot. (E) Cells were transfected with scrambled, NIK, IKKα, or IKKβ siRNA, and then incubated with TNF-α for 10 min.
The protein levels of phospho-IKKα/β, phospho-p65, NIK, IKKα, and IKKβ were determined. Data are expressed as mean ± SEM of three independent experiments.
∗P < 0.05, #P < 0.01 as compared with the cells exposed to TNF-α alone.
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FIGURE 7 | Schematic representation of the signaling pathways involved in the TNF-α-induced cPLA2 expression in HPAEpiCs. The mechanisms
underlying TNF-α-mediated activation of TNFR1/TRAF2/ASK1/p47phox-dependent NADPH oxidase is required for the expression of cPLA2 in HPAEpiCs. Finally, the
activation of ROS/NIK/IKKα/β/NF-κB pathway led to cPLA2 gene transcription and PGE2 release.
inflammatory responses (Khanapure et al., 2007). TNF-α has
been shown to activate cPLA2 gene and involves in the late-
phase airway hyperresponsiveness and inflammation (Choi et al.,
2005), but few studies address the intracellular signaling pathways
leading to its expression. It is showed that TNF-α activates ASK1,
NADPH oxidase/ROS, IKKα/β, and NF-κB pathways in several
cell types (Lee et al., 2009, 2011; Byeon et al., 2012). However,
whether these signaling molecules participated in cPLA2
expression in TNF-α-treated HPAEpiCs was not completely
defined. In this study, Figure 7 addressed that pretreatment with
the inhibitors of NADPH oxidase (APO and DPI), ROS (NAC),
or NF-κB (Bay11-7082) or transfection with siRNA of ASK1,
TRAF2, p47phox, NIK, IKKα, IKKβ, or p65 attenuated TNF-
α-induced cPLA2 expression and PGE2 production in HPAEpiCs.
Our studies confirmed that activation of NADPH oxidase, ROS,
NIK, IKKα/β, and NF-κB via association of TNFR1, TRAF2,
ASK1, and p47phox may be essential for cPLA2 expression in TNF-
α-stimulated HPAEpiCs. cPLA2 induction and TNF-α-induced
complex formation of TNFR1, TRAF2, ASK1, and p47phox
were blocked by pretreatment with TNF-α neutralizing antibody.
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These results suggested that up-regulation of cPLA2 by TNF-α
is, at least in part, mediated through the cooperation of TNFR1,
TRAF2, ASK1, and NADPH oxidase leading to ROS generation
and ultimately activates NF-κB pathway.
Several reports indicate that TNF-α may regulate
inflammatory protein expression via activating various
downstream protein kinases (Lin et al., 2004; Lee et al.,
2009). Effects of TNF-α are achieved by binding to one of
two distinct receptors, known as TNFR1 and TNFR2 (Lee
et al., 2009). However, it is reported that TNF-α activates the
proinflammatory or the programmed cell death pathways
leading to tissue injury via binding to TNFR1 (van Vliet
et al., 2005; Lee et al., 2009). In contrast, TNFR2 is involved
in promoting tissue repair and angiogenesis (Bradley, 2008).
Indeed, transfection with TNFR1 siRNA attenuated NADPH
oxidase and ROS generation, revealing that TNFR1 plays a key
role in modulating inflammatory responses in TNF-α-stimulated
HPAEpiCs.
Reactive oxygen species are generated by various enzymatic
reactions and chemical processes or can directly be inhaled from
environment (Lee and Yang, 2012). Formation of ROS takes
place constantly in every cell during normal metabolic processes.
Activated phagocytic cells could produce large amounts of
ROS induced by inhaled particles, microorganisms, or other
mediators leading to the activation of the membrane-bound
NADPH oxidase complex and the generation of superoxide anion
(Lee and Yang, 2012). NADPH oxidase is recognized to be a
key player in the generation of ROS when the cells or tissues
exposed to various insults. Upon activation of NADPH oxidase
by various stimuli, the complex of catalytic subunit (gp91phox)
and p22phox is anchored in plasma membrane which assembles
with the regulatory subunits (p47phox, p40phox, p67phox, and
small GTPase Rac) distributed in cytoplasm and leading to ROS
generation (El-Benna et al., 2008). The initiation of the assembly
NADPH oxidase is first dependent on the phosphorylation of
p47phox triggered by various activated protein kinases. Thus,
p47phox plays a role in the membrane translocation and ROS
generation. Indeed, our results confirmed that blockage ROS
accumulation either by a ROS scavenger (NAC), the inhibitors
of NADPH oxidase (DPI and APO) or transfection with p47phox
siRNA significantly attenuated TNF-α-induced cPLA2 expression
and PGE2 synthesis. DPI or APO pretreatment reduced TNF-
α-stimulated ROS generation. These results revealed that TNF-
α increased cPLA2/PGE2 expression via NADPH oxidase-
dependent ROS generation. p47phox is phosphorylated on several
serine residues within the polybasic region of the protein, and
these multiple phosphorylation events induce conformational
changes that permit p47phox to interact with the cytoplasmic tail
of p22phox and to initiate the formation of the active oxidase
(Dang et al., 2006). In lung endothelial cells, Src regulates tyrosine
phosphorylation of p47phox in hyperoxia-induced activation of
NADPH oxidase and generation of ROS (Chowdhury et al.,
2005). Moreover, in HPAEpiCs, we found that TNF-α could
stimulate both serine and tyrosine phosphorylation of p47phox,
and then promotes p47phox translocation from the cytosol to the
membrane.
TRAF2 plays a central role in the cellular responses to stress
and cytokines via their regulation of stress kinases, resulting
in the activation of key transcription factors, including NF-κB,
c-Jun, and ATF2. Upon exposure to TNF-α, TRAF2 is recruited
directly to TNFR2 or via TRADD to TNFR1, which results in
the activation of JNK1/2, p38 MAPK and NF-κB (Cabal-Hierro
and Lazo, 2012). However, our previous report indicated that
Jak2 also mediates the TNF-α-induced cPLA2 expression (Yang
et al., 2014). To evaluate the relationship between Jak2 and
MAPKs pathways, we have performed some more experiments
to determine whether there is any connection between MAPKs
and Jak2 using pharmacological inhibitors (AG490, SB202190,
SP600125 and U0126). We found that pretreatment with AG490
had no effect on TNF-α-stimulated MAPKs phosphorylation, or
with MAPK inhibitors (SB202190, SP600125 and U0126) failed to
inhibit Jak2 phosphorylation (Supplementary Figure S1). These
results suggested that Jak2 and MAPKs are independent pathways
to mediate the TNF-α-induced cPLA2 expression. Here, we also
found that TNF-α-induced cPLA2 expression and PGE2 release
were markedly inhibited by blockage TRAF2. In addition, we
also observed that TNF-α induced TNFR1 and TRAF2 complex
formation. Previous study indicated that TNF-α stimulated the
formation of a TNFR1/c-Src/p47phox complex in human airway
smooth muscle cells (Lee et al., 2009). Here, we demonstrated that
TNF-α induced TNFR1, TRAF2, and p47phox complex formation
which was blocked by pretreatment with TNF-α neutralizing
antibody, and leading to cPLA2 expression in HPAEpiCs.
ASK1, a member of the MAP3K family, regulates the
activation of MAPK kinase 4 (MKK4)/MKK7-JNK and MKK3/6-
p38 pathways. ASK1 can be activated by various types of stresses,
such as ROS, TNF-α, and ER stress, and exerts pivotal roles
in regulating cell apoptosis, differentiation, and inflammation
(Fujino et al., 2007). Therefore, unregulated ASK1 activation
is tightly related to various diseases. Moreover, we found
that inhibition of ASK1 markedly reduced TNF-α-induced
cPLA2 expression and PGE2 release. TNF-α also stimulated
ASK1 phosphorylation in these cells. Upon exposure to ROS,
Trx dissociated from the N-terminal of ASK1, which then
became fully activated by recruitment of TRAF2 and TRAF6
(Fujino et al., 2007). Indeed, we found consistent results
that TNF-α induces TRAF2 and ASK1 complex formation
which is also blocked by pretreatment with TNF-α neutralizing
antibody. In this study, we are the first to show a novel role
of TNFR1/TRAF2/ASK1/p47phox complex formation in TNF-
α-induced NADPH oxidase activation and ROS production in
HPAEpiCs. In the future, we will further determine which
domains of TNFR1, TRAF2, ASK1, and p47phox are involved in
protein-protein interactions caused by TNF-α. Although ROS
have been shown to regulate ASK1 activation (Fujino et al.,
2007), in this study, we emphasized the critical role of ASK1
in TNF-α-induced ROS generation. Thus, in addition to the
role of ROS in ASK1 activation, our results supported that the
opposite hierarchical relationship exists between ROS and ASK1.
Therefore, NADPH oxidase/ROS may act both as upstream
regulators and downstream effectors of ASK1 in various cell
types.
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The NF-κB/Rel family complex, a redox-sensitive
transcription factor, participates in controlling expression
of many inflammatory genes (Sun, 2011). NF-κB usually forms
herterodimer by p50 and p65/RelA subunits. In resting cells,
nuclear translocation signal of NF-κB is masked by binding with
an inhibitor protein called inhibitory κB (IκB) as an inactive
non-DNA-binding form. Upon the stimulation by various NF-κB
inducers, two serine residues of IκBα is phosphorylated, which
then being ubiquinated by E3 ubiquitin-ligases (E3RSIκB) and
subsequently degraded by the 26S proteasome (Sun, 2011). The
released NF-κB dimers can then translocate into the nucleus
and bind to the κB elements on the promoter of target genes.
NIK was first identified as a TRAF2 interacting protein (Tak
and Firestein, 2001). In inactive form, NF-κB transcription
factors binds with the inhibitory proteins IκBs. IKKα and IKKβ
regulates the phosphorylation of IκB proteins, which then being
ubiquitination and degradation leading to nuclear localization
of NF-κB transcription factors (Sun, 2011). In this study,
inhibition of NIK, IKKα, IKKβ, and NF-κB markedly inhibited
TNF-α-induced cPLA2 expression. Various extracellular stimuli
such as TNF-α and IL-1β, viruses and environmental particulates
(PM10s), and oxidative stress regulate the activation of NF-κB
(Sun, 2011). Here, we reported that TNF-α time-dependently
induced phosphorylation and translocation of NF-κB p65 and
NF-κB promoter activity via an NADPH oxidase/ROS pathway.
Otherwise, we also proved that TNF-α significantly induced
IKKα/β phosphorylation via an NIK-dependent signaling, and
then promoted NF-κB activation. Thus, we recognized that
TNF-α-induced ROS generation may promote activation of the
NIK/IKKα/β/NF-κB pathway in HPAEpiCs.
COX-2 and cPLA2 are tightly regulated by various mediators
in several species (Beasley, 1999; Ali et al., 2008; Pavicevic et al.,
2008). cPLA2 hydrolyzes the membrane phospholipids, resulting
in the release of AA, which is further converted by the constitutive
enzyme COX-1 or by the inducible COX-2, and PG synthases to
biologically active PGs (DeWitt, 1999). On the other hand, several
reports indicated that the levels of PGE2 are also degraded by
an important enzyme, 15-hydroxyprostaglandin dehydrogenase
(15-PGDH) to regulate the levels of PGEs (Pomini et al., 1999;
Otani et al., 2006; Thiel et al., 2009). In our previous study, up-
regulation of COX-2 in TSMCs has been shown to enhance PGE2
synthesis induced by LPS (Luo et al., 2003). Moreover, we also
provided insights into the correlation between COX-2 and cPLA2
expression in ATPγS-stimulated VSMCs with similar molecular
mechanisms and functional coupling to amplify the occurrence
of vascular inflammation (Lin et al., 2009). PGE2 treatment also
induced cPLA2 expression in VSMCs, which exerted as a positive
feedback regulator in this response (Lin et al., 2009). Therefore,
the synthesis of PGE2 could be a good index of AA release
that is more sensitive than [3H]AA mobilization (Berenbaum
et al., 2003) and PGE2 may further induce cPLA2 expression
to amplify the occurrence of pulmonary inflammation. In this
study, although the effect of PGE2 on COX-2 expression was not
investigated, we tested the effect of TNF-α on PGE2 synthesis as a
parameter of cPLA2 activity which may be an important issue for
further study in HPAEpiCs.
CONCLUSION
According to the literature reports and our results, Figure 7
addresses a model for the molecular mechanisms of TNF-
α-stimulated cPLA2 expression and PGE2 release in
HPAEpiCs. To our knowledge, this is the first study to
indicate that in HPAEpiCs, TNF-α-regulated activation
of TNFR1/TRAF2/ASK1/p47phox-dependent NADPH
oxidase is required for the expression of cPLA2. Finally,
activation of the ROS/NIK/IKKα/β/NF-κB pathway
leads to cPLA2 gene activation and expression. It is an
important link for TNF-α-regulated cPLA2 expression
in the pathogenesis of lung inflammatory diseases.
Therefore, uncovering the signaling components in TNF-
α-mediated cPLA2 expression in HPAEpiCs is important
to develop new therapeutic strategies in pulmonary
diseases.
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